查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1880580

犬类疫苗市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032 年）

Canine Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

犬类疫苗市场成长推动因素

全球犬类疫苗市场持续稳定成长，主要受宠物饲养量增加、预防性兽医保健意识提高以及政府和产业对人畜共通传染病防控日益重视的推动。根据最新市场数据，在已开发国家和新兴国家广泛开展疫苗接种的推动下，犬类疫苗市场规模在 2024 年达到 18.7 亿美元。考虑到人们持续努力维护宠物健康、疫苗平台不断进步以及兽医基础设施不断完善，预计该市场规模将在 2025 年加速增长至 19.5 亿美元，并在 2032 年达到 30.4 亿美元。

市场成长推动因素

推动市场成长的最主要因素是全球犬隻数量的快速成长。宠物主人越来越将狗视为家庭成员，这推动了对先进兽医护理服务（包括常规疫苗接种）的投资增加。仅在美国，全球动物健康协会报告称，就有大约8,500万隻宠物狗，为疫苗的长期需求奠定了坚实的基础。人们对犬流感、莱姆病、狂犬病和犬小病毒等传染病的日益关注，进一步强化了及时接种疫苗的必要性。

政府措施也大大促进了市场扩张。鑑于人畜共通传染病带来的公共卫生风险，世界各国政府都在推广大规模疫苗接种计画。加大对公共卫生教育的投入、与兽医协会的合作以及免费或补贴疫苗接种活动，都在推动疫苗接种率的提高。同时，可支配收入的增加和宠物人性化趋势的日益增长，也推高了兽医护理成本。

市场限制因子

儘管成长前景乐观，但该产业仍面临一些阻碍因素。部分宠物主人对疫苗接种的犹豫态度减缓了市场普及速度，这主要是由于担心潜在的副作用以及缺乏对疫苗接种频率和必要性的认识。根据全球疫苗免疫联盟（GAVI）的数据，4%的犬和12%的猫尚未接种狂犬病疫苗，凸显了加强宣传和教育计画的必要性。

另一个主要障碍是兽医专业人员短缺。世界各地的兽医诊所仍在努力招募人，导致预约名额减少和就诊量下降。根据美国兽医协会（AVMA）的报告，2021年至2023年，客户就诊量下降了2.7%，这可能会阻碍疫苗接种率的持续提高。

市场机会

市场为新型联合疫苗的开发提供了巨大的机会。这些配方可以用更少的剂量提供对多种疾病的保护，从而提高便利性并增强免疫反应。例如，2025年7月，礼来公司（Elanco）的下一代犬流感结合疫苗TruCan Ultra CIV H3N2/H3N8获得了美国农业部（USDA）的批准，该疫苗采用了PureFil技术。该产品旨在最大限度地减少副作用。

人畜共通传染病的日益普及以及人们对宠物全面照护的日益关注，也促使製药公司开发重组疫苗和精准标靶疫苗。监管支持的加强以及对兽医研发投入的增加，进一步拓展了该领域的创新机会。

市场趋势

犬类疫苗产业的关键趋势是向更容易给药的疫苗剂型转变，特别是鼻内和口服疫苗。这些给药方式可以减轻宠物的压力，最大限度地减少操作要求，并快速激活粘膜免疫反应。 2025年3月，硕腾（Zoetis）推出了0.5毫升的Vanguard B鼻内疫苗，可有效预防博德氏菌感染。这显示市场正朝着更便利的疫苗接种方式转变。

区域洞察

北美 - 市场领导者

预计2024年，北美将占全球市场最大占有率，达到8.4亿美元，占全球收入的44.91%。该地区受益于较高的宠物拥有率、先进的兽医实践以及硕腾（Zoetis）、默克（Merck & Co.）和礼来（Elanco）等主要生产商的强大影响力。由于严格的犬类疫苗接种指南和不断增长的宠物医疗保健支出，美国仍然是最大的贡献者。

欧洲

预计欧洲市场将实现显着成长，这主要得益于人们对犬类疾病风险的认识不断提高以及宠物拥有率的不断上升。英国有28%的成年人养狗，是推动区域扩张的主要市场。

亚太地区

预计到2032年，亚太地区将经历最快的成长速度。城市地区宠物拥有率的上升、新产品的推出以及诸如Biobeta与印度Betina Healthcare的合作等伙伴关係，都在支持该市场的快速发展。

拉丁美洲、中东和非洲

预计这些地区将经历缓慢但稳定的成长，这主要得益于政府主导的狂犬病疫苗接种计划以及人们对伴侣动物健康意识的提高。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家/地区犬类疾病概览（2024 年）
  • 主要国家/地区监管状况（2024 年）
  • 犬类疾病疫苗接种概览
  • 主要公司新技术应用
  • 主要产业趋势（併购、合作等）

第五章：全球犬类疫苗市场分析、洞察与预测 (2019-2032)

  • 市场分析、洞察与预测 - 依技术分类
    • 灭活​​疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测 - 依疾病类型分类
    • 犬流感
    • 莱姆病
    • 狂犬病
    • 钩端螺旋体病
    • 其他
  • 市场分析、洞察与预测 - 依给药途径分类
    • 口服
    • 注射
    • 鼻腔给药
  • 市场分析、洞察与预测 - 依销售管道分类
    • 兽医院
    • 兽药诊所
    • 药局和药局
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美犬类疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲犬类疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 德国
    • 美国王国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区犬类疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲犬类疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

章节10：中东和非洲犬类疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市占率分析（2024）
  • 公司简介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
  • Indian Immunologicals Ltd.
  • HIPRA
  • Brilliant Bio Pharma(India)
Product Code: FBI113897

Growth Factors of canine vaccines Market

The global canine vaccines market continues its steady expansion, driven by rising pet ownership, growing awareness of preventive veterinary care, and increasing government and industry focus on combating zoonotic diseases. According to the latest market data, the canine vaccines market size reached USD 1.87 billion in 2024, supported by strong vaccination adoption across developed and emerging economies. The market is projected to rise to USD 1.95 billion in 2025 and further accelerate to USD 3.04 billion by 2032, reflecting the sustained commitment to pet health, advancements in vaccine platforms, and expansion of veterinary infrastructure.

Market Growth Drivers

The most influential driver of market growth is the rapid rise in global dog ownership. Pet parents increasingly view dogs as family members, leading to growing investments in advanced veterinary services, including routine and preventive vaccinations. In the U.S. alone, the Global Animal Health Association reported around 85 million pet dogs, presenting a strong foundation for long-term vaccine demand. Growing concerns about infectious diseases such as canine influenza, Lyme disease, rabies, and parvovirus further strengthen the necessity for timely immunization.

Government initiatives also contribute substantially to market expansion. With zoonotic diseases posing public health risks, authorities across the world are promoting mass vaccination programs. Increased investment in public health education, partnerships with veterinary associations, and free or subsidized vaccination campaigns encourage higher adoption rates. Simultaneously, rising disposable income and the broader pet humanization trend support increased veterinary expenditures.

Market Restraints

Despite positive growth prospects, the industry faces a few restraints. Vaccine hesitancy among a segment of pet owners slows market adoption, primarily due to concerns about potential side effects or lack of awareness about the frequency and necessity of vaccinations. According to GAVI, 4% of dogs and 12% of cats remain unvaccinated against rabies, highlighting the need for enhanced outreach and educational programs.

Another significant barrier is the shortage of veterinary professionals. Veterinary practices worldwide continue to experience limited staff availability, resulting in reduced appointment capacity and a decline in clinic visits. Between 2021 and 2023, the American Veterinary Medical Association reported a 2.7% decline in client visits, which may hinder consistent immunization compliance.

Market Opportunities

The market is witnessing strong opportunities in the development of novel combination vaccines. These formulations provide multi-disease protection with fewer doses, improving convenience and enhancing immune response. For example, Elanco received USDA approval in July 2025 for TruCan Ultra CIV H3N2/H3N8, a next-generation canine influenza combination vaccine using PureFil Technology to minimize adverse reactions.

The growing prevalence of zoonotic diseases and heightened focus on comprehensive pet care are also pushing pharmaceutical companies toward developing recombinant and precision-targeted vaccines. Strengthened regulatory support and rising investments in veterinary R&D further expand opportunities for innovation in this sector.

Market Trends

A leading trend in the canine vaccines industry is the shift toward easy-to-administer vaccine formats, particularly intranasal and oral vaccines. These modes reduce stress on pets, minimize handling requirements, and activate rapid mucosal immune responses. In March 2025, Zoetis introduced the Vanguard B Intranasal vaccine, a 0.5 mL formulation offering protection against Bordetella bronchiseptica, showcasing the market's movement toward user-friendly vaccine delivery.

Regional Insights

North America - Market Leader

North America held the largest share of the global market in 2024, valued at USD 0.84 billion, representing 44.91% of global revenue. The region benefits from high pet adoption, advanced veterinary care, and significant presence of leading manufacturers such as Zoetis, Merck & Co., and Elanco. The U.S. remains the largest contributor due to strong guidelines for canine vaccination and increased spending on companion animal healthcare.

Europe

Europe is expected to exhibit considerable growth, supported by increasing awareness of canine disease risks and higher pet ownership. The U.K., with 28% of adults owning dogs, is a key contributor to regional expansion.

Asia Pacific

Asia Pacific is forecast to grow at the fastest rate through 2032. The rise in urban pet ownership, new product introductions, and partnerships-such as Bioveta's collaboration with Vetina Healthcare in India-support rapid market development.

Latin America & Middle East & Africa

These regions show moderate but steady growth, strongly supported by government-led rabies vaccination programs and rising awareness of companion animal health.

Competitive Landscape

The market is semi-fragmented, with major players including Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Ceva, Bioveta, Indian Immunologicals Ltd., HIPRA, and Brilliant Bio Pharma. These companies are expanding through new product launches, multi-disease vaccine development, strategic partnerships, and investment in advanced manufacturing capabilities.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Canine Influenza
  • Lyme Disease
  • Rabies
  • Leptospirosis
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Canine Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Canine Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Canine Influenza
    • 5.2.2. Lyme Disease
    • 5.2.3. Rabies
    • 5.2.4. Leptospirosis
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Intranasal
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Canine Influenza
    • 6.2.2. Lyme Disease
    • 6.2.3. Rabies
    • 6.2.4. Leptospirosis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Canine Influenza
    • 7.2.2. Lyme Disease
    • 7.2.3. Rabies
    • 7.2.4. Leptospirosis
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Intranasal
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Technology
    • 7.5.1. Inactivated
    • 7.5.2. Live Attenuated
    • 7.5.3. Recombinant
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Disease Type
    • 7.6.1. Canine Influenza
    • 7.6.2. Lyme Disease
    • 7.6.3. Rabies
    • 7.6.4. Leptospirosis
    • 7.6.5. Others
  • 7.7. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.7.1. Oral
    • 7.7.2. Parenteral
    • 7.7.3. Intranasal
  • 7.8. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.8.1. Veterinary Hospitals
    • 7.8.2. Veterinary Clinics
    • 7.8.3. Pharmacies & Drug Stores
    • 7.8.4. Others
  • 7.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.9.1. Germany
    • 7.9.2. U.K.
    • 7.9.3. France
    • 7.9.4. Italy
    • 7.9.5. Spain
    • 7.9.6. Scandinavia
    • 7.9.7. Rest of Europe

8. Asia Pacific Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Canine Influenza
    • 8.2.2. Lyme Disease
    • 8.2.3. Rabies
    • 8.2.4. Leptospirosis
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Intranasal
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Canine Influenza
    • 9.2.2. Lyme Disease
    • 9.2.3. Rabies
    • 9.2.4. Leptospirosis
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
    • 9.3.3. Intranasal
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Canine Influenza
    • 10.2.2. Lyme Disease
    • 10.2.3. Rabies
    • 10.2.4. Leptospirosis
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
    • 10.3.3. Intranasal
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.
    • 11.2.8. Indian Immunologicals Ltd.
    • 11.2.9. HIPRA
    • 11.2.10. Brilliant Bio Pharma (India)

List of Tables

  • Table 1: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 2: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 3: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 4: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 5: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 6: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 7: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 8: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 9: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 10: North America Canine Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 11: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 12: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 13: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 14: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 15: Europe Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 17: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 18: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 19: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 20: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 22: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 23: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 24: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 25: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 26: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 27: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 28: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 29: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 30: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Canine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Canine Vaccines Market Value Share (%), by Technology, 2024 & 2032
  • Figure 3: Global Canine Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
  • Figure 4: Global Canine Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Canine Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 6: Global Canine Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 7: North America Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 8: North America Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 9: North America Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 10: North America Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 11: North America Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 12: North America Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 13: North America Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 14: North America Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 15: North America Canine Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 16: North America Canine Vaccines Market Value Share (%), By Country, 2024
  • Figure 17: Europe Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 18: Europe Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 19: Europe Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 20: Europe Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 21: Europe Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 22: Europe Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 23: Europe Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 24: Europe Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 25: Europe Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 26: Europe Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 27: Asia Pacific Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 28: Asia Pacific Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 29: Asia Pacific Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 30: Asia Pacific Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 31: Asia Pacific Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 32: Asia Pacific Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 33: Asia Pacific Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 34: Asia Pacific Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 35: Asia Pacific Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Asia Pacific Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Latin America Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 38: Latin America Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 39: Latin America Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 40: Latin America Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 41: Latin America Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Latin America Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Latin America Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 44: Latin America Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 45: Latin America Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 46: Latin America Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 47: Middle East & Africa Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 48: Middle East & Africa Canine Vaccines Market Value Share (%), by Technology, 2024
  • Figure 49: Middle East & Africa Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 50: Middle East & Africa Canine Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 51: Middle East & Africa Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 52: Middle East & Africa Canine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 53: Middle East & Africa Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 54: Middle East & Africa Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 55: Middle East & Africa Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 56: Middle East & Africa Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 57: Global Canine Vaccines Market Share (%), By Company, 2024